Masayuki Teramoto

Masayuki Teramoto

Auto-generated profile, based on publicly available information

Masayuki Teramoto

Department of Preventive Cardiology, National Cerebral and Cardiovascular Center , 6-1, Kishibe-Shinmachi, Suita, Osaka 564-8565

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
MTMasayuki Teramoto
Masayuki Teramoto
KYKazumasa Yamagishi
Kazumasa Yamagishi
IMIsao Muraki
Isao Muraki
ATAkiko Tamakoshi
Akiko Tamakoshi
HIHiroyasu Iso
Hiroyasu Iso
Background: This study was conducted to examine the impacts of coffee and green tea consumption on cardiovascular disease (CVD) mortality among people with severe hypertension. Methods and Results: In the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk), 18 609 participants (6574 men and 12 035 women) aged 40 to 79 years at baseline who completed a lifestyle, diet, and medical history questionnaire, and health examinations, were followed up until 2009. We classified the participants into four blood pressure (BP) categories: optimal and normal BP, high‐normal BP, grade 1 hypertension, and grade 2–3 hypertension. A Cox proportional hazard model was used to calculate the multivariable hazard ratios with 95% CIs of CVD mortality. During the 18.9 years of median follow‐up, a total of 842 CVD deaths were documented. Coffee consumption was associated with an increased risk of CVD mortality among people with grade 2–3 hypertension; the multivariable hazard ratios (95% CI) of CVD mortality were 0.98 (0.67–1.43) for <1 cup/day, 0.74 (0.37–1.46) for 1 cup/day, and 2.05 (1.17–3.59) for ≥2 cups/day, compared with non–coffee drinkers. Such associations were not found among people with optimal and normal, high‐normal BP, and grade 1 hypertension. Green tea consumption was not associated with an increased risk of CVD across any BP categories. Conclusions: Heavy coffee consumption was associated with an increased risk of CVD mortality among people with severe hypertension, but not people without hypertension and with grade 1 hypertension. In contrast, green tea consumption was not associated with an increased risk of CVD mortality across all categories of BP.

12 May 2025 in JMIR Cardio
Verified
Journal Article
Open access
TVThien Vu
Thien Vu
YKYoshihiro Kokubo
Yoshihiro Kokubo
MIMai Inoue
Mai Inoue
MYMasaki Yamamoto
Masaki Yamamoto
Attayeb MohsenAttayeb Mohsen
Attayeb Mohsen
MAMichihiro Araki
Michihiro Araki
Background: Coronary heart disease (CHD) is a major cause of morbidity and mortality worldwide. Identifying key risk factors is essential for effective risk assessment and prevention. A data-driven approach using machine learning (ML) offers advanced techniques to analyze complex, nonlinear, and high-dimensional datasets, uncovering novel predictors of CHD that go beyond the limitations of traditional models, which rely on predefined variables. Objective: This study aims to evaluate the contribution of various risk factors to CHD, focusing on both established and novel markers using ML techniques. Methods: The study recruited 7672 participants aged 30-84 years from Suita City, Japan, between 1989 and 1999. Over an average of 15 years, participants were monitored for cardiovascular events. A total of 7260 participants and 28 variables were included in the analysis after excluding individuals with missing outcome data and eliminating unnecessary variables. Five ML models—logistic regression, random forest (RF), support vector machine, Extreme Gradient Boosting, and Light Gradient-Boosting Machine—were applied for predicting CHD incidence. Model performance was evaluated using accuracy, sensitivity, specificity, precision, area under the curve, F1-score, calibration curves, observed-to-expected ratios, and decision curve analysis. Additionally, Shapley Additive Explanations (SHAPs) were used to interpret the prediction models and understand the contribution of various risk factors to CHD. Results: Among 7260 participants, 305 (4.2%) were diagnosed with CHD. The RF model demonstrated the highest performance, with an accuracy of 0.73 (95% CI 0.64‐0.80), sensitivity of 0.74 (95% CI 0.62‐0.84), specificity of 0.72 (95% CI 0.61‐0.83), and an area under the curve of 0.73 (95% CI 0.65‐0.80). RF also showed excellent calibration, with predicted probabilities closely aligning with observed outcomes, and provided substantial net benefit across a range of risk thresholds, as demonstrated by decision curve analysis. SHAP analysis elucidated key predictors of CHD, including the intima-media thickness (IMT_cMax) of the common carotid artery, blood pressure, lipid profiles (non–high-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), and estimated glomerular filtration rate. Novel risk factors identified as significant contributors to CHD risk included lower calcium levels, elevated white blood cell counts, and body fat percentage. Furthermore, a protective effect was observed in women, suggesting the potential necessity for gender-specific risk assessment strategies in future cardiovascular health evaluations. Conclusions: We developed a model to predict CHD using ML and applied SHAP methods for interpretation. This approach highlights the multifactor nature of CHD risk evaluation, aiming to support health care professionals in identifying risk factors and formulating effective prevention strategies.

2 January 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
MTMasayuki Teramoto
Masayuki Teramoto
YKYoshihiro Kokubo
Yoshihiro Kokubo
AAAhmed Arafa
Ahmed Arafa
RKRena Kashima
Rena Kashima
YNYoko M. Nakao
Yoko M. Nakao
HKHiroharu Kataoka
Hiroharu Kataoka
Background: The utility of screening for the degree of common carotid artery (CCA) stenosis as a predictor of cardiovascular disease (CVD) in a general population remains unclear. Methods and Results: We studied 4775 Japanese men and women whose CCA was measured using bilateral carotid ultrasonography at baseline (April 1994–August 2001). We calculated the degree of stenosis as a percentage of the stenotic area of the lumen in the cross‐section perpendicular to the long axis. The Cox proportional hazards model was used to calculate multivariable‐adjusted hazard ratios (HRs) with 95% CIs for incident CVD and its subtypes according to the degree of CCA stenosis. During the median 14.2 years of follow‐up, 385 incident CVD events (159 coronary heart disease and 226 stroke) were documented. The degree of CCA stenosis was associated with increased risks of incident CVD, coronary heart disease, and stroke, with multivariable‐adjusted HRs (95% CIs) for <25%, 25%–49%, and ≥50% stenosis with plaque compared with no CCA plaque of 1.37 (1.07–1.76), 1.72 (1.23–2.40), and 2.49 (1.69–3.67), respectively. Adding the CCA stenosis degree to traditional CVD risk factors increased Harrell's C statistics (0.772 [95% CI, 0.751–0.794] to 0.778 [95% CI, 0.758–0.799]; P =0.04) and improved the 10‐year risk prediction ability (integrated discrimination improvement, 0.0129 [95% CI, 0.0078–0.0179]; P <0.001; continuous net reclassification improvement, 0.1598 [95% CI, 0.0297–0.2881]; P =0.01). Conclusions: The degree of CCA stenosis may be used as a predictive marker for the development of CVD in the general population.

1 March 2026 in Circulation: Population Health and Outcomes
Verified
Journal Article
Closed access
MTMasayuki Teramoto
Masayuki Teramoto
JTJames Gregory Terry
James Gregory Terry
MPMark J. Pletcher
Mark J. Pletcher
GMGregory M. Marcus
Gregory M. Marcus
THThomas J. Hoffmann
Thomas J. Hoffmann
KYKristine Yaffe
Kristine Yaffe
BACKGROUND: We aimed to examine how coronary artery calcium (CAC) and its progression relate to cognitive function in midlife, an important time for cognitive aging. METHODS: We studied participants enrolled in the prospective CARDIA (Coronary Artery Risk Development in Young Adults) study, a longitudinal cohort of Black and White adults aged 18 to 30 years at baseline, who completed CAC measurements using computed tomography at year 15 (2000–2001; our baseline), had at least 1 follow-up CAC measurement at years 20 (2005–2006) or 25 (2010–2011), and completed cognitive assessments with a battery of 5 tests at years 30 (2015–2016) or 35 (2020–2022). CAC progression was defined as: (1) CAC >0 at follow-up among participants with baseline CAC=0; (2) an annualized change of ≥10 units at follow-up among those with 00 (9%) was associated with lower processing speed, verbal memory, and global cognition, whereas CAC progression (26%) was associated with lower processing speed and global cognition after adjusting for demographics, education, physical activity, depressive symptoms, APOE ε4 allele, and baseline CAC score. The standardized cognitive differences (95% CI) for CAC progression versus no progression were −0.14 (95% CI, −0.23 to −0.06) for the Digit Symbol Substitution Test and −0.09 (95% CI, −0.17 to −0.01) for the Montreal Cognitive Assessment. CONCLUSIONS: CAC progression was associated with worse midlife processing speed and global cognition, independent of baseline CAC score and established risk factors. Repeated CAC assessments may offer clinical value for identifying individuals at increased risk for midlife cognitive decline.

7 October 2026 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
MTMasayuki Teramoto
Masayuki Teramoto
YKYoshihiro Kokubo
Yoshihiro Kokubo
YKYuka Kato
Yuka Kato
SSSakura Shinohara
Sakura Shinohara
PKParamita Khairan
Paramita Khairan
HKHiroharu Kataoka
Hiroharu Kataoka
Aims: The aim of this study was to investigate the long-term association between lipoprotein(a) [Lp(a)] and the longitudinal continuum of carotid atherosclerosis, from initial plaque formation to progression to carotid stenosis, in a prospective study of a general Japanese population. Methods and results: We studied 3272 participants in the Suita Study (mean age: 58.0 ± 11.5 years; 57.9% women) who were free of cardiovascular disease and carotid plaque at baseline (1995–2004). Follow-up carotid ultrasonography was performed biennially until June 2016. Incident carotid plaque was defined as a maximal intima–media thickness (IMT) ≥ 1.7 mm in the entire carotid artery. Progression from plaque to stenosis was defined as ≥50% stenosis in participants who developed plaques. We employed Cox proportional hazards models for incident plaques, linear mixed-effects models for annual IMT changes, and logistic regression for progression to stenosis. During a median follow-up of 11.5 years, 1432 participants developed carotid plaques. Compared with Lp(a) < 15 mg/dL, the multivariable-adjusted hazard ratio for incident plaque was 1.27 [95% confidence interval (CI), 1.01–1.61] for Lp(a) ≥ 50 mg/dL. Participants with Lp(a) ≥ 50 mg/dL had significantly accelerated annual progression of maximal IMT (β = 0.014 mm/year; 95% CI, 0.003–0.025) compared with those with Lp(a) < 15 mg/dL. Furthermore, high Lp(a) levels were associated with progression to ≥50% carotid stenosis (multivariable-adjusted odds ratio, 2.29; 95% CI, 1.15–4.57). Conclusion: Elevated Lp(a) levels (≥ 50 mg/dL) were associated with the longitudinal continuum of carotid atherosclerosis, from plaque initiation to advanced stenosis. These findings suggest that high Lp(a) levels serve as a robust marker for long-term cardiovascular risk accumulation, highlighting the importance of screening and potential targeted interventions in individuals with Lp(a) ≥ 50 mg/dL.